Evidence map›Paper›PMID 36309531›Full record

ArticleNature communications2022

Integration of Hi-C with short and long-read genome sequencing reveals the structure of germline rearranged genomes.

Robert Schöpflin, Uirá Souto Melo, Hossein Moeinzadeh, David Heller, Verena Laupert, Jakob Hertzberg, Manuel Holtgrewe, Nico Alavi, Marius-Konstantin Klever, Julius Jungnitsch and 21 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Enhancer activation from transposable elements in extrachromosomal DNA.bioRxiv : the preprint server for biology · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 15 institutions in 6 countries.

Robert Schöpflin *Max Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany.
Uirá Souto Melo *Max Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany.
Hossein MoeinzadehMax Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, Berlin, Germany.
David HellerMax Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, Berlin, Germany.
Verena LaupertMax Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, Berlin, Germany.
Jakob HertzbergMax Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany.
Manuel HoltgreweCUBI-Core Unit Bioinformatics, Berlin Institute of Health, Berlin, Germany.ORCID 0000-0002-3051-1763
Nico AlaviMax Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, Berlin, Germany.ORCID 0000-0002-4621-8879
Marius-Konstantin KleverMax Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany.
Julius JungnitschMax Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany.
Emel ComakMax Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, Berlin, Germany.
Seval TürkmenInstitute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.
Denise HornInstitute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.
Yannis DuffourdUFR Des Sciences de Santé, INSERM-Université de Bourgogne UMR1231 GAD « Génétique des Anomalies du Développement », FHU-TRANSLAD, Dijon, France.
Laurence FaivreUFR Des Sciences de Santé, INSERM-Université de Bourgogne UMR1231 GAD « Génétique des Anomalies du Développement », FHU-TRANSLAD, Dijon, France.
Patrick CallierUFR Des Sciences de Santé, INSERM-Université de Bourgogne UMR1231 GAD « Génétique des Anomalies du Développement », FHU-TRANSLAD, Dijon, France.
Damien SanlavilleDepartment of Medical Genetics, University Hospital of Lyon, 69007, Lyon, France.
Orsetta ZuffardiMedical Genetics, Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Romano TenconiGenetica Clinica, Dipartimento di Pediatria, Università di Padova, Padova, Italy.
Nehir Edibe KurtasMedical Genetics Unit, Meyer Children's University Hospital, Florence, Italy.
Sabrina GiglioMedical Genetics Unit, University of Cagliari, Cagliari, Italy.
Bettina PragerPraxis für Humangenetik, Kinderzentrum Dresden-Friedrichstadt, Dresden, Germany.
Anna Latos-BielenskaDepartment of Medical Genetics, University of Medical Sciences in Poznan, Poznan, Poland.
Ida VogelDepartment for Clinical Medicine, Aarhus University, Aarhus, Denmark.
Merete BuggeWilhelm Johannsen Center for Functional Genome Research, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
Niels TommerupWilhelm Johannsen Center for Functional Genome Research, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.
Malte SpielmannMax Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany.
Antonio VitobelloUFR Des Sciences de Santé, INSERM-Université de Bourgogne UMR1231 GAD « Génétique des Anomalies du Développement », FHU-TRANSLAD, Dijon, France.ORCID 0000-0003-3717-8374
Vera M KalscheuerMax Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany.ORCID 0000-0001-6898-3259
Martin VingronMax Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, Berlin, Germany. vingron@molgen.mpg.de.ORCID 0000-0002-1765-4241
Stefan MundlosMax Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany. stefan.mundlos@charite.de.ORCID 0000-0002-9788-3166
Max Planck Institute for Molecular Genetics · DEInserm · FRUniversity of Copenhagen · DKAarhus University · DKBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DECharité - Universitätsmedizin Berlin · DEChristian-Albrechts-Universität zu Kiel · DEHospices Civils de Lyon · FRLaboratoire National de Santé · LUMeyer Children's Hospital · ITPoznan University of Medical Sciences · PLPraxis für Humangenetik · DEUniversity of Cagliari · ITUniversity of Padua · ITUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Structural variants are a common cause of disease and contribute to a large extent to inter-individual variability, but their detection and interpretation remain a challenge. Here, we investigate 11 individuals with complex genomic rearrangements including germline chromothripsis by combining short- and long-read genome sequencing (GS) with Hi-C. Large-scale genomic rearrangements are identified in Hi-C interaction maps, allowing for an independent assessment of breakpoint calls derived from the GS methods, resulting in >300 genomic junctions. Based on a comprehensive breakpoint detection and Hi-C, we achieve a reconstruction of whole rearranged chromosomes. Integrating information on the three-dimensional organization of chromatin, we observe that breakpoints occur more frequently than expected in lamina-associated domains (LADs) and that a majority reshuffle topologically associating domains (TADs). By applying phased RNA-seq, we observe an enrichment of genes showing allelic imbalanced expression (AIG) within 100 kb around the breakpoints. Interestingly, the AIGs hit by a breakpoint (19/22) display both up- and downregulation, thereby suggesting different mechanisms at play, such as gene disruption and rearrangements of regulatory information. However, the majority of interpretable genes located 200 kb around a breakpoint do not show significant expression changes. Thus, there is an overall robustness in the genome towards large-scale chromosome rearrangements.

Indexed as

ChromatinGenomeBase SequenceChromosome MappingGerm CellsHumansChromatin

Identifiers

PMID36309531
PMCPMC9617858
OpenAlexW4307846315

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.